Related Experiment Video

Updated: Aug 1, 2026

Minimal Invasive Surgical Procedure of Inducing Myocardial Infarction in Mice
09:05

Minimal Invasive Surgical Procedure of Inducing Myocardial Infarction in Mice

Published on: May 4, 2015

Interventional therapy for acute myocardial infarction

M A Siddiqui1, N Tandon, L Mosley

  • 1Department of Medicine, Louisiana State University Health Sciences Center, Shreveport, Louisiana, USA.

The Journal of the Louisiana State Medical Society : Official Organ of the Louisiana State Medical Society
|August 2, 2001
PubMed

Insights

Percutaneous transluminal coronary angioplasty is a safer and more effective treatment for acute ST-elevation myocardial infarction than thrombolytic therapy. This intervention reduces mortality and complications, especially when performed promptly by experienced teams.

Area of Science:

  • Cardiology
  • Interventional Cardiology
  • Acute Myocardial Infarction Treatment

Background:

  • Acute ST-elevation myocardial infarction (STEMI) poses significant mortality risks.
  • Thrombolytic therapy has been a traditional treatment, but with limitations.

Purpose of the Study:

  • To evaluate the efficacy and safety of percutaneous transluminal coronary angioplasty (PTCA) compared to thrombolytic therapy for STEMI.
  • To highlight the benefits of PTCA as a rescue procedure and in specific patient populations.

Main Methods:

  • Review of clinical outcomes comparing PTCA and thrombolytic therapy in acute myocardial infarction.
  • Analysis of data regarding mortality, intracerebral hemorrhage, and vessel patency.
  • Inclusion of outcomes with glycoprotein IIb-IIIa inhibitors and stent placement.

Main Results:

  • PTCA demonstrates superior efficacy and safety over thrombolytic therapy for acute STEMI.
  • Coronary intervention significantly decreases early mortality and intracerebral hemorrhage incidence.
  • PTCA is effective as a rescue procedure after failed fibrinolysis, restoring vessel patency and reducing mortality.
  • Glycoprotein IIb-IIIa inhibitors enhance PTCA outcomes, particularly with stent placement.
  • PTCA offers benefits in patients with cardiogenic shock, saphenous vein graft occlusions, diabetes mellitus, and the elderly.

Conclusions:

  • Percutaneous transluminal coronary angioplasty is the preferred treatment for acute ST-elevation myocardial infarction.
  • Timely intervention by experienced teams improves patient outcomes and reduces complications.
  • Ongoing research into new devices and drugs promises further advancements in interventional therapy for myocardial infarction.

More Related Videos

Postconditioning with Lactate-enriched Blood for Cardioprotection in ST-segment Elevation Myocardial Infarction05:26

Postconditioning with Lactate-enriched Blood for Cardioprotection in ST-segment Elevation Myocardial Infarction

Published on: May 28, 2019

Interventional Diagnostic Procedure: A Practical Guide for the Assessment of Coronary Vascular Function10:28

Interventional Diagnostic Procedure: A Practical Guide for the Assessment of Coronary Vascular Function

Published on: March 15, 2022

Related Concept Videos

Myocarditis III: Medical Management01:14

Myocarditis III: Medical Management

Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
Angina IV: Management01:26

Angina IV: Management

IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...
Cardiopulmonary Resuscitation IV: Pharmacological Management01:25

Cardiopulmonary Resuscitation IV: Pharmacological Management

Pharmacologic intervention is crucial in treating cardiac arrest patients during ACLS or Advanced Cardiovascular Life Support. The ACLS algorithms guide the administration of specific drugs based on the patient's cardiac arrest rhythm, which includes pulseless ventricular tachycardia (VT), ventricular fibrillation (VF), asystole, and pulseless electrical activity (PEA).EpinephrineIndication: Epinephrine is the first-line drug for all cardiac arrest rhythms.Mechanism of Action: Epinephrine...
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
Peripheral Artery Disease III: Interprofessional Care01:27

Peripheral Artery Disease III: Interprofessional Care

Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...